Elevated serum levels of calcitonin gene-related peptide in Hymenoptera sting-induced anaphylaxis

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 1, 1998, Pages 149-151

  Volcheck, Gerald W ^a   Butterfield, Joseph H ^a   Yunginger, John W ^a   Klee, George G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; VASODILATOR AGENT;

ANAPHYLAXIS; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HYMENOPTERA; HYPOTENSION; INSECT STING; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RADIOIMMUNOASSAY; VASODILATATION;

EID: 0031843380     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70068-5     Document Type: Article

References (6)

1. Brain SD, Cambridge H. Calcitonin gene related peptide: vasoactive effects and potential therapeutic role. Gen Pharmacol 1996;27:607-11.
2. Preibisz JJ. Calcitonin gene-related peptide and regulations of human cardiovascular homeostasis. Am J Hypertens 1993;6:434-50.
3. Struthers AD, Brown MJ, MacDonald DWR, Beacham JL, Stevenson JC, Morris HR, et al. Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci 1986;70:389-93.
4. Butterfield JH, Kao PC, Klee GG, Yocum MW. Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization. Mayo Clin Proc 1995;70:481-7.
5. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989;83:1551-5.
6. Schuligoi R, Amann R, Donnerer J, Peskar BA. Release of calcitonin gene-related peptide in cardiac anaphylaxis. Nauyn Schmiedebergs Arch Pharmacol 1997;355:224-9.